Want to join the conversation?
$ARNA 2Q15 Call: ARNA is prepared for a start later this year of its multiple ascending dose study of APD371, a highly selective and potent cannabinoid 2 (CB2) receptor agonist in development for the treatment of pain. Phase 1 single ascending dose study showed excellent tolerability.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.